|
1
|
Soengas MS and Lowe SW: Apoptosis and
melanoma chemo-resistance. Oncogene. 22:3138–3151. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hersey P, Zhuang L and Zhang XD: Current
strategies in overcoming resistance of cancer cells to apoptosis
melanoma as a model. Int Rev Cytol. 251:131–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sykes EK, Mactier S and Christopherson RI:
Melanoma and the Unfolded Protein Response. Cancers (Basel).
8:82016. View Article : Google Scholar
|
|
4
|
Sharma A, Shah SR, Illum H and Dowell J:
Vemurafenib: Targeted inhibition of mutated BRAF for treatment of
advanced melanoma and its potential in other malignancies. Drugs.
72:2207–2222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao D, Johnson CS, Trump DL and Singh SV:
Proteasome-mediated degradation of cell division cycle 25C and
cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced
G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
Mol Cancer Ther. 3:567–575. 2004.PubMed/NCBI
|
|
6
|
Yeh YT, Yeh H, Su SH, Lin JS, Lee KJ, Shyu
HW, Chen ZF, Huang SY and Su SJ: Phenethyl isothiocyanate induces
DNA damage-associated G2/M arrest and subsequent apoptosis in oral
cancer cells with varying p53 mutations. Free Radic Biol Med.
74:1–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Øverby A, Zhao CM, Bones AM and Chen D:
Naturally occurring phenethyl isothiocyanate-induced inhibition of
gastric cancer cell growth by disruption of microtubules. J
Gastroenterol Hepatol. 29(Suppl 4): 99–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chou YC, Chang MY, Wang MJ, Liu HC, Chang
SJ, Harnod T, Hung CH, Lee HT, Shen CC and Chung JG: Phenethyl
isothiocyanate alters the gene expression and the levels of protein
associated with cell cycle regulation in human glioblastoma GBM
8401 cells. Environ Toxicol. 32:176–187. 2017. View Article : Google Scholar
|
|
9
|
Huong D, Shim JH, Choi KH, Shin JA, Choi
ES, Kim HS, Lee SJ, Kim SJ, Cho NP and Cho SD: Effect of
β-phenylethyl isothiocyanate from cruciferous vegetables on growth
inhibition and apoptosis of cervical cancer cells through the
induction of death receptors 4 and 5. J Agric Food Chem.
59:8124–8131. 2011. View Article : Google Scholar
|
|
10
|
Hwang ES and Lee HJ: Effects of
phenylethyl isothiocyanate and its metabolite on cell-cycle arrest
and apoptosis in LNCaP human prostate cancer cells. Int J Food Sci
Nutr. 61:324–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan H, Zhu Y, Liu B, Wu H, Li Y, Wu X,
Zhou Q and Xu K: Mitogen-activated protein kinase mediates the
apoptosis of highly metastatic human non-small cell lung cancer
cells induced by isothiocyanates. Br J Nutr. 106:1779–1791. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu C, Shen G, Chen C, Gélinas C and Kong
AN: Suppression of NF-kappaB and NF-kappaB-regulated gene
expression by sulforaphane and PEITC through IkappaBalpha, IKK
pathway in human prostate cancer PC-3 cells. Oncogene.
24:4486–4495. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bommareddy A, Hahm ER, Xiao D, Powolny AA,
Fisher AL, Jiang Y and Singh SV: Atg5 regulates phenethyl
isothiocyanate-induced autophagic and apoptotic cell death in human
prostate cancer cells. Cancer Res. 69:3704–3712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kelloff GJ, Crowell JA, Hawk ET, Steele
VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P,
et al: Strategy and planning for chemopreventive drug development:
Clinical development plans II. J Cell Biochem. (Suppl 26): 54–71.
1996. View Article : Google Scholar
|
|
15
|
Chen HJ, Lin CM, Lee CY, Shih NC, Amagaya
S, Lin YC and Yang JS: Phenethyl isothiocyanate suppresses
EGF-stimulated SAS human oral squamous carcinoma cell invasion by
targeting EGF receptor signaling. Int J Oncol. 43:629–637.
2013.PubMed/NCBI
|
|
16
|
Tang L and Zhang Y: Dietary
isothiocyanates inhibit the growth of human bladder carcinoma
cells. J Nutr. 134:2004–2010. 2004.PubMed/NCBI
|
|
17
|
Xiao D, Powolny AA and Singh SV: Benzyl
isothiocyanate targets mitochondrial respiratory chain to trigger
reactive oxygen species-dependent apoptosis in human breast cancer
cells. J Biol Chem. 283:30151–30163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Batra S, Sahu RP, Kandala PK and
Srivastava SK: Benzyl isothiocyanate-mediated inhibition of histone
deacetylase leads to NF-kappaB turnoff in human pancreatic
carcinoma cells. Mol Cancer Ther. 9:1596–1608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu KC, Huang YT, Wu PP, Ji BC, Yang JS,
Yang JL, Chiu TH, Chueh FS and Chung JG: The roles of AIF and Endo
G in the apoptotic effects of benzyl isothiocyanate on DU 145 human
prostate cancer cells via the mitochondrial signaling pathway. Int
J Oncol. 38:787–796. 2011.PubMed/NCBI
|
|
20
|
Huang SH, Wu LW, Huang AC, Yu CC, Lien JC,
Huang YP, Yang JS, Yang JH, Hsiao YP, Wood WG, et al: Benzyl
isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in
human melanoma A375.S2 cells through reactive oxygen species (ROS)
and both mitochondria-dependent and death receptor-mediated
multiple signaling pathways. J Agric Food Chem. 60:665–675. 2012.
View Article : Google Scholar
|
|
21
|
Zhou T, Li G, Cao B, Liu L, Cheng Q, Kong
H, Shan C, Huang X, Chen J and Gao N: Downregulation of Mcl-1
through inhibition of translation contributes to benzyl
isothiocyanate-induced cell cycle arrest and apoptosis in human
leukemia cells. Cell Death Dis. 4:e5152013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang NY, Chueh FS, Yu CC, Liao CL, Lin JJ,
Hsia TC, Wu KC, Liu HC, Lu KW and Chung JG: Benzyl isothiocyanate
alters the gene expression with cell cycle regulation and cell
death in human brain glioblastoma GBM 8401 cells. Oncol Rep.
35:2089–2096. 2016.PubMed/NCBI
|
|
23
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cruz-Munoz W and Khokha R: The role of
tissue inhibitors of metalloproteinases in tumorigenesis and
metastasis. Crit Rev Clin Lab Sci. 45:291–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee CS, Cho HJ, Jeong YJ, Shin JM, Park
KK, Park YY, Bae YS, Chung IK, Kim M, Kim CH, et al:
Isothiocyanates inhibit the invasion and migration of C6 glioma
cells by blocking FAK/JNK-mediated MMP-9 expression. Oncol Rep.
34:2901–2908. 2015.PubMed/NCBI
|
|
26
|
Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q
and Xu K: Isothiocyanates induce oxidative stress and suppress the
metastasis potential of human non-small cell lung cancer cells. BMC
Cancer. 10:2692010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shih YL, Chou J, Yeh MY, Chou HM, Chou HC,
Lu HF, Shang HS, Chueh FS, Chu YL, Hsueh SC, et al: Casticin
induces DNA damage and inhibits DNA repair-associated protein
expression in B16F10 mouse melanoma cancer cells. Oncol Rep.
36:2094–2100. 2016.PubMed/NCBI
|
|
28
|
Chen YY, Lu HF, Hsu SC, Kuo CL, Chang SJ,
Lin JJ, Wu PP, Liu JY, Lee CH, Chung JG, et al: Bufalin inhibits
migration and invasion in human hepatocellular carcinoma SK-Hep1
cells through the inhibitions of NF-κB and matrix
metalloproteinase-2/-9-signaling pathways. Environ Toxicol.
30:74–2. 2015. View Article : Google Scholar
|
|
29
|
Huang YP and Chang NW: PPARα modulates
gene expression profiles of mitochondrial energy metabolism in oral
tumorigenesis. Biomedicine (Taipei). 6:32016. View Article : Google Scholar
|
|
30
|
Huang AC, Yang MD, Hsiao YT, Lin TS, Ma
YS, Peng SF, Hsia TC, Cheng YD, Kuo CL and Chung JG: Bufalin
inhibits gefitinib resistant NCI-H460 human lung cancer cell
migration and invasion in vitro. J Ethnopharmacol. 194:1043–1050.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan CY, Lien CH, Lee MF and Huang CY:
Quercetin suppresses cellular migration and invasion in human head
and neck squamous cell carcinoma (HNSCC). Biomedicine (Taipei).
6:152016. View Article : Google Scholar
|
|
32
|
Lin M-C, Tsai S-Y, Wang F-Y, Liu F-H, Syu
J-N and Tang F-Y: Leptin induces cell invasion and the upregulation
of matrilysin in human colon cancer cells. BioMedicine. 3:pp.
174–180. 2013, http://biomedicine.cmu.edu.tw/doc/9-5.pdf.
View Article : Google Scholar
|
|
33
|
Kuo TC, Yang JS, Lin MW, Hsu SC, Lin JJ,
Lin HJ, Hsia TC, Liao CL, Yang MD, Fan MJ, et al: Emodin has
cytotoxic and protective effects in rat C6 glioma cells: Roles of
Mdr1a and nuclear factor kappaB in cell survival. J Pharmacol Exp
Ther. 330:736–744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin (Shanghai). 40:643–650. 2008. View Article : Google Scholar
|
|
35
|
Jia W, Gao XJ, Zhang ZD, Yang ZX and Zhang
G: S100A4 silencing suppresses proliferation, angiogenesis and
invasion of thyroid cancer cells through downregulation of MMP-9
and VEGF. Eur Rev Med Pharmacol Sci. 17:1495–1508. 2013.PubMed/NCBI
|
|
36
|
Kallakury BV, Karikehalli S, Haholu A,
Sheehan CE, Azumi N and Ross JS: Increased expression of matrix
metalloproteinases 2 and 9 and tissue inhibitors of
metalloproteinases 1 and 2 correlate with poor prognostic variables
in renal cell carcinoma. Clin Cancer Res. 7:3113–3119.
2001.PubMed/NCBI
|
|
37
|
Yoshizaki T, Maruyama Y, Sato H and
Furukawa M: Expression of tissue inhibitor of matrix
metalloproteinase-2 correlates with activation of matrix
metalloproteinase-2 and predicts poor prognosis in tongue squamous
cell carcinoma. Int J Cancer. 95:44–50. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hsieh YS, Chu SC, Hsu LS, Chen KS, Lai MT,
Yeh CH and Chen PN: Rubus idaeus L. reverses
epithelial-to-mesenchymal transition and suppresses cell invasion
and protease activities by targeting ERK1/2 and FAK pathways in
human lung cancer cells. Food Chem Toxicol. 62:908–918. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng
Y, Zhang J and Liu Y: PI3K/Akt is involved in bufalin-induced
apoptosis in gastric cancer cells. Anticancer Drugs. 20:59–64.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rajoria S, Suriano R, George A, Shanmugam
A, Schantz SP, Geliebter J and Tiwari RK: Estrogen induced
metastatic modulators MMP-2 and MMP-9 are targets of
3,3′-diindolylmethane in thyroid cancer. PLoS One. 6:e158792011.
View Article : Google Scholar
|
|
41
|
Chu SC, Yu CC, Hsu LS, Chen KS, Su MY and
Chen PN: Berberine reverses epithelial-to-mesenchymal transition
and inhibits metastasis and tumor-induced angiogenesis in human
cervical cancer cells. Mol Pharmacol. 86:609–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
D'Orazio D, Besser D, Marksitzer R, Kunz
C, Hume DA, Kiefer B and Nagamine Y: Cooperation of two PEA3/AP1
sites in uPA gene induction by TPA and FGF-2. Gene. 201:179–187.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mori Y, Akita K, Tanida S, Ishida A, Toda
M, Inoue M, Yashiro M, Sawada T, Hirakawa K and Nakada H: MUC1
protein induces urokinase-type plasminogen activator (uPA) by
forming a complex with NF-κB p65 transcription factor and binding
to the uPA promoter, leading to enhanced invasiveness of cancer
cells. J Biol Chem. 289:35193–35204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Offenberg H, Brünner N, Mansilla F,
Orntoft Torben F and Birkenkamp-Demtroder K: TIMP-1 expression in
human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1,
TNF-AIP6 and TIMP-2 transcript profiles. Mol Oncol. 2:233–240.
2008. View Article : Google Scholar
|
|
45
|
Pulyaeva H, Bueno J, Polette M, Birembaut
P, Sato H, Seiki M and Thompson EW: MT1-MMP correlates with MMP-2
activation potential seen after epithelial to mesenchymal
transition in human breast carcinoma cells. Clin Exp Metastasis.
15:111–120. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Heppner KJ, Matrisian LM, Jensen RA and
Rodgers WH: Expression of most matrix metalloproteinase family
members in breast cancer represents a tumor-induced host response.
Am J Pathol. 149:273–282. 1996.PubMed/NCBI
|
|
47
|
Eisenmann KM, VanBrocklin MW, Staffend NA,
Kitchen SM and Koo HM: Mitogen-activated protein kinase
pathway-dependent tumor-specific survival signaling in melanoma
cells through inactivation of the proapoptotic protein bad. Cancer
Res. 63:8330–8337. 2003.PubMed/NCBI
|
|
48
|
Junttila MR, Li SP and Westermarck J:
Phosphatase-mediated crosstalk between MAPK signaling pathways in
the regulation of cell survival. FASEB J. 22:954–965. 2008.
View Article : Google Scholar
|
|
49
|
Lee KR, Lee JS, Kim YR, Song IG and Hong
EK: Polysaccharide from Inonotus obliquus inhibits migration and
invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via
down-regulation of NF-κB signaling pathway. Oncol Rep.
31:2447–2453. 2014.PubMed/NCBI
|
|
50
|
Mori T, Wang X, Aoki T and Lo EH:
Downregulation of matrix metalloproteinase-9 and attenuation of
edema via inhibition of ERK mitogen activated protein kinase in
traumatic brain injury. J Neurotrauma. 19:1411–1419. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shin DY, Lu JN, Kim GY, Jung JM, Kang HS,
Lee WS and Choi YH: Anti-invasive activities of anthocyanins
through modulation of tight junctions and suppression of matrix
metalloproteinase activities in HCT-116 human colon carcinoma
cells. Oncol Rep. 25:567–572. 2011.
|
|
52
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lin BW, Jiao ZL, Fan JF, Peng L, Li L,
Zhao ZG, Ding XY and Li HJ: Inhibitory effect of melanoma
differentiation associated gene-7/interleukin-24 on invasion in
vitro of human melanoma cancer cells. J Korean Med Sci. 28:833–839.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim D, Kim S, Koh H, Yoon SO, Chung AS,
Cho KS and Chung J: Akt/PKB promotes cancer cell invasion via
increased motility and metalloproteinase production. FASEB J.
15:1953–1962. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shukla S, Maclennan GT, Hartman DJ, Fu P,
Resnick MI and Gupta S: Activation of PI3K-Akt signaling pathway
promotes prostate cancer cell invasion. Int J Cancer.
121:1424–1432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shi H, Wu Y, Wang Y, Zhou M, Yan S, Chen
Z, Gu D and Cai Y: Liquiritigenin potentiates the inhibitory
effects of cisplatin on invasion and metastasis via downregulation
MMP-2/9 and PI3K/AKT signaling pathway in B16F10 melanoma cells and
mice model. Nutr Cancer. 67:761–770. 2015. View Article : Google Scholar
|
|
57
|
Thang ND, Yajima I, Kumasaka MY, Iida M,
Suzuki T and Kato M: Deltex-3-like (DTX3L) stimulates metastasis of
melanoma through FAK/PI3K/AKT but not MEK/ERK pathway. Oncotarget.
6:14290–14299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Qiao M, Sheng S and Pardee AB: Metastasis
and AKT activation. Cell Cycle. 7:2991–2996. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Narumiya S, Tanji M and Ishizaki T: Rho
signaling, ROCK and mDia1, in transformation, metastasis and
invasion. Cancer Metastasis Rev. 28:65–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
